H18.601

Clinical Causes: Genetic factors: A family history of keratoconus or other corneal conditions. Environmental influences: Chronic eye rubbing or exposure to UV light may contribute to development. Biochemical abnormalities: Changes in the enzymes that maintain corneal structure. Associated conditions: Some connective tissue disorders, such as Marfan syndrome or Ehlers-Danlos syndrome.

Key Symptoms: Blurred or distorted vision that worsens over time. Sensitivity to bright lights and glare. Sudden or progressive worsening of vision. Frequent changes in prescription glasses or contact lenses prescription. Haloes or ghost images around lights, especially at night. Lasik surgery complications if performed on a keratoconic eye.

Diagnosis Path: Diagnosing keratoconus involves a thorough eye examination including visual acuity tests and specific imaging techniques such as corneal topography or tomography. These tests map the shape of the cornea with high precision, revealing characteristic cone-shaped protrusions. Additional assessments may include slit-lamp examination to observe corneal thinning or scarring. A diagnosis of keratoconus in the right eye is made based on clinical findings supported by imaging interpretations, with the ICD-10 code H18.601 assigned for this specific condition.

Treatment Protocols: Eyeglasses or soft contact lenses in early stages for mild vision correction. Specialized rigid gas-permeable contact lenses or scleral lenses as the disease advances to improve vision. Corneal cross-linking: A minimally invasive procedure that strengthens corneal tissue to halt or slow disease progression. Intrastromal corneal rings: Small implantable devices that reshape the cornea and reduce cone protrusion. Astigmatic keratotomy: Surgical incisions to modify corneal shape. Corneal transplantation: In severe cases where other treatments cannot restore vision, procedures such as penetrating keratoplasty or deep anterior lamellar keratoplasty may be considered. Regular monitoring: Essential for tracking disease progression and adjusting treatment plans accordingly.